Safety Alert
Frequently Asked Questions (FAQs) (Alert)
Inspection and Compliance (Alert)
Students – Exams and Internship (Alert)
Premises License (Alert)
Practice License (Alert)
NS
Sodium Chloride Intravenous Infusion BP 0.9% w/v
What it does
Intravenous (IV) therapy involves delivering medications or fluids directly into the bloodstream through a vein.
Commonly used for: dehydration, infections, surgery recovery, pain management …
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.
Sourcing - Kenya onlyRegistration & product details
Source: Rwanda Food and Drugs Authority · fetched 2026-03-11 22:07:36 · updated 2026-09-21 02:30:20
About this medicine
Intravenous (IV) therapy involves delivering medications or fluids directly into the bloodstream through a vein.
What it treats
- dehydration
- infections
- surgery recovery
- pain management
- nutrition support
How it works
IV therapy allows quick delivery of fluids and medications, helping to treat various conditions effectively.
Who it's for
IV therapy is suitable for patients who cannot take medications by mouth or need immediate treatment.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: intravenous
Intravenous (IV) administration refers to the delivery of substances directly into the bloodstream through a vein. This method is commonly used for the rapid delivery of medications, fluids, and nutrients, allowing for immediate systemic effects. IV administration is vital in emergency situations, surgical procedures, and for patients who cannot take medications orally.
Indications
- Dehydration
- Electrolyte imbalances
- Infections requiring immediate antibiotic therapy
- Pain management in acute settings
- Nutritional support in patients unable to eat
- Chemotherapy administration
- Anesthesia induction and maintenance
Dosage
Children: Refer to the specific drug's prescribing information in the BNF for Children for appropriate dosing guidelines.
Adults: Refer to the specific drug's prescribing information in the BNF for appropriate dosing guidelines.
Mechanism of action
The mechanism of action for intravenous drugs depends on the specific medication administered. Generally, intravenous administration allows for rapid drug distribution throughout the body, achieving high plasma concentrations quickly. This is particularly beneficial for medications that require immediate therapeutic effects.
Pharmacodynamics
Pharmacodynamics varies based on the specific drug administered intravenously. In general, drugs delivered via IV can achieve peak plasma concentrations faster than those taken orally, leading to quicker onset of action. This route is often utilized for drugs that are poorly absorbed in the gastrointestinal tract or for those that require precise titration to achieve the desired therapeutic effect.
Pharmacokinetics
Pharmacokinetics for intravenous drugs typically includes immediate bioavailability since the drug is delivered directly into circulation. Distribution is rapid, and elimination depends on the drug's specific metabolic pathways. Volume of distribution, clearance rates, and half-life can significantly vary based on the drug's properties and patient factors such as age, body weight, and organ function.
Interactions
- ataluren + intravenous aminoglycosides: Severe (increases risk of nephrotoxicity)
- intravenous dantrolene + calcium channel blockers: Severe (increases risk of acute hyperkalaemia and cardiovascular collapse)
- intravenous dantrolene + diltiazem: Severe (increases risk of acute hyperkalaemia and cardiovascular collapse)
- intravenous dantrolene + verapamil: Severe (increases risk of acute hyperkalaemia and cardiovascular collapse)
- intravenous chloramphenicol + antiepileptics: Moderate (increases concentration)
- intravenous chloramphenicol + fosphenytoin: Moderate (increases concentration)
- intravenous chloramphenicol + phenytoin: Moderate (increases concentration)
- miconazole + intravenous benzodiazepines: Moderate (increases exposure)
- intravenous magnesium + calcium channel blockers: Unknown (increases risk of hypotension)
- intravenous magnesium + amlodipine: Unknown (increases risk of hypotension)
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.
This drug in other countries
The same active ingredient registered across other registries we cover - including different brands.